• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞转录组分析揭示了肺腺癌中自然杀伤细胞基因特征对肿瘤的免疫浸润。

Single cell transcriptomic analysis reveals tumor immune infiltration by NK cells gene signature in lung adenocarcinoma.

作者信息

Zhu Yimin, Wu Xiuhua, Zhang Yunjiao, Gu Jie, Zhou Rongwei, Guo Zhong

机构信息

Department of Pulmonary and Critical Care Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Heliyon. 2024 Jul 2;10(13):e33928. doi: 10.1016/j.heliyon.2024.e33928. eCollection 2024 Jul 15.

DOI:10.1016/j.heliyon.2024.e33928
PMID:39071697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11283104/
Abstract

BACKGROUND

Natural Killer (NK) cells are vital components of the innate immune system, crucial for combating infections and tumor growth, making them pivotal in cancer prognosis and immunotherapy. We sought to understand the diverse characteristics of NK cells within lung adenocarcinoma (LUAD) by conducting single-cell RNA sequencing analyses.

METHODS

Using the scRNA-seq dataset for multiple primary lung cancers (MPLCs), we examined two major NK cell groups, NK1 and NK2, comparing the expression profiles of 422 differentially expressed NK signature genes. We identified eight genes (SPON2, PLEKHG3, CAMK2N1, RAB27B, CTBP2, EFHD2, GOLM1, and PLOD1) that distinguish NK1 from NK2 cells. A prognostic signature, the NK gene signature (NKGS) score, was established through LASSO Cox regression. High NKGS scores were linked to poorer overall survival in TCGA-LUAD patients and consistently validated in other datasets (GSE31210 and GSE14814).

RESULTS

Functional analysis revealed an enrichment of genes related to the TGF-β signaling pathway in the high NKGS score group. Moreover, a high NKGS score correlated with an immunosuppressive tumor microenvironment (TME) driven by immune evasion mechanisms. We also observed reduced T-cell receptor (TCR) repertoire diversity in the high-risk NKGS group, indicating a negative association between inflammation and risk score.

CONCLUSION

This study introduced the innovative NKGS score, differentiating NK1 from NK2 cells. High NKGS scores were associated with the TGF-β pathway and provided insights into LUAD prognosis and immune activities.

摘要

背景

自然杀伤(NK)细胞是先天免疫系统的重要组成部分,对抵抗感染和肿瘤生长至关重要,使其在癌症预后和免疫治疗中发挥关键作用。我们试图通过进行单细胞RNA测序分析来了解肺腺癌(LUAD)中NK细胞的多样特征。

方法

利用多个原发性肺癌(MPLC)的scRNA-seq数据集,我们检查了两个主要的NK细胞组,NK1和NK2,比较了422个差异表达的NK特征基因的表达谱。我们鉴定出八个区分NK1和NK2细胞的基因(SPON2、PLEKHG3、CAMK2N1、RAB27B、CTBP2、EFHD2、GOLM1和PLOD1)。通过LASSO Cox回归建立了一个预后特征,即NK基因特征(NKGS)评分。高NKGS评分与TCGA-LUAD患者较差的总生存期相关,并在其他数据集(GSE31210和GSE14814)中得到一致验证。

结果

功能分析显示,高NKGS评分组中与TGF-β信号通路相关的基因富集。此外,高NKGS评分与由免疫逃逸机制驱动的免疫抑制肿瘤微环境(TME)相关。我们还观察到高风险NKGS组中T细胞受体(TCR)库多样性降低,表明炎症与风险评分之间存在负相关。

结论

本研究引入了创新的NKGS评分,区分了NK1和NK2细胞。高NKGS评分与TGF-β通路相关,并为LUAD的预后和免疫活动提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/6f905d89cebf/mmcfigs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/db02bb963363/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/873cc3e35295/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/57f8cf1820ad/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/e33435764d0f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/82827dcf8e11/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/41914ac13c27/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/4a2912c67496/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/5f8d777acefc/mmcfigs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/0a9e8017f3d2/mmcfigs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/7b6274d869ee/mmcfigs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/6f905d89cebf/mmcfigs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/db02bb963363/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/873cc3e35295/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/57f8cf1820ad/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/e33435764d0f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/82827dcf8e11/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/41914ac13c27/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/4a2912c67496/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/5f8d777acefc/mmcfigs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/0a9e8017f3d2/mmcfigs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/7b6274d869ee/mmcfigs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/11283104/6f905d89cebf/mmcfigs4.jpg

相似文献

1
Single cell transcriptomic analysis reveals tumor immune infiltration by NK cells gene signature in lung adenocarcinoma.单细胞转录组分析揭示了肺腺癌中自然杀伤细胞基因特征对肿瘤的免疫浸润。
Heliyon. 2024 Jul 2;10(13):e33928. doi: 10.1016/j.heliyon.2024.e33928. eCollection 2024 Jul 15.
2
Deciphering the immune heterogeneity dominated by natural killer cells with prognostic and therapeutic implications in hepatocellular carcinoma.解析以自然杀伤细胞为主导的免疫异质性及其在肝细胞癌中的预后和治疗意义。
Comput Biol Med. 2023 May;158:106872. doi: 10.1016/j.compbiomed.2023.106872. Epub 2023 Apr 4.
3
Identification and Validation of a Novel Signature Based on NK Cell Marker Genes to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing.基于 NK 细胞标记基因的新型标志物的鉴定和验证,通过单细胞和批量 RNA 测序的综合分析预测肺腺癌的预后和免疫治疗反应。
Front Immunol. 2022 Jun 10;13:850745. doi: 10.3389/fimmu.2022.850745. eCollection 2022.
4
Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.单细胞与批量RNA测序的综合分析揭示肺腺癌中巨噬细胞极化相关基因的预后特征
Int J Gen Med. 2023 Nov 3;16:5031-5050. doi: 10.2147/IJGM.S430408. eCollection 2023.
5
Prognosis and immunotherapy significances of a cancer-associated fibroblasts-related gene signature in lung adenocarcinoma.肺癌腺癌中癌症相关成纤维细胞相关基因特征的预后及免疫治疗意义
Cell Mol Biol (Noisy-le-grand). 2023 Dec 20;69(14):51-61. doi: 10.14715/cmb/2023.69.14.9.
6
A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma.基于单细胞 RNA 测序的肺腺癌肿瘤微环境中免疫细胞相互作用的新型预后标志物研究。
J Immunol Res. 2022 Jul 1;2022:6555810. doi: 10.1155/2022/6555810. eCollection 2022.
7
Single-cell sequencing analysis and transcriptome analysis constructed the macrophage related gene-related signature in lung adenocarcinoma and verified by an independent cohort.单细胞测序分析和转录组分析构建了肺腺癌中与巨噬细胞相关基因相关的特征,并通过独立队列进行了验证。
Genomics. 2022 Nov;114(6):110520. doi: 10.1016/j.ygeno.2022.110520. Epub 2022 Nov 11.
8
Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma.鉴定与 TGF-β 信号相关的基因特征,用于预测肺腺癌的免疫治疗和靶向治疗。
World J Surg Oncol. 2022 Jun 6;20(1):183. doi: 10.1186/s12957-022-02595-1.
9
Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.利用单细胞 RNA 测序数据开发与转移相关的七个基因标志物,用于预测肺腺癌预后。
Math Biosci Eng. 2021 Jul 1;18(5):5959-5977. doi: 10.3934/mbe.2021298.
10
Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma.泛癌分析确定了蛋白酶体26S亚基、ATP酶(PSMC)家族基因,以及与肺腺癌预后、免疫特征和治疗反应相关的特征。
Front Genet. 2023 Jan 9;13:1017866. doi: 10.3389/fgene.2022.1017866. eCollection 2022.

本文引用的文献

1
Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer.整合单细胞和批量 RNA 测序以预测前列腺癌的预后和免疫治疗反应。
Sci Rep. 2023 Sep 20;13(1):15597. doi: 10.1038/s41598-023-42858-9.
2
Improved understanding of NSCLC immunotherapy response mechanisms from single-cell analysis.通过单细胞分析对非小细胞肺癌免疫治疗反应机制有了更深入的了解。
Transl Lung Cancer Res. 2023 Aug 30;12(8):1807-1811. doi: 10.21037/tlcr-23-428. Epub 2023 Aug 8.
3
Advances in single-cell RNA sequencing and its applications in cancer research.
单细胞 RNA 测序技术的进展及其在癌症研究中的应用。
J Hematol Oncol. 2023 Aug 24;16(1):98. doi: 10.1186/s13045-023-01494-6.
4
A pan-cancer single-cell panorama of human natural killer cells.人类自然杀伤细胞的泛癌症单细胞全景图。
Cell. 2023 Sep 14;186(19):4235-4251.e20. doi: 10.1016/j.cell.2023.07.034. Epub 2023 Aug 21.
5
Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers.人类多原发肺癌中细胞组成和空间结构的多向性特征。
Cell Death Dis. 2023 Jul 25;14(7):462. doi: 10.1038/s41419-023-05992-w.
6
Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment.基因组数据与生物标志物的进展:革新非小细胞肺癌的诊断与治疗
Cancers (Basel). 2023 Jul 3;15(13):3474. doi: 10.3390/cancers15133474.
7
Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing.基于单细胞 RNA 测序的肺癌有前景的免疫治疗靶点。
Front Immunol. 2023 Apr 28;14:1148061. doi: 10.3389/fimmu.2023.1148061. eCollection 2023.
8
The Long Run towards Personalized Therapy in Non-Small-Cell Lung Cancer: Current State and Future Directions.非小细胞肺癌个体化治疗的漫漫征途:现状与未来方向。
Int J Mol Sci. 2023 May 4;24(9):8212. doi: 10.3390/ijms24098212.
9
An integrated single-cell transcriptomic dataset for non-small cell lung cancer.非小细胞肺癌的综合单细胞转录组数据集。
Sci Data. 2023 Mar 27;10(1):167. doi: 10.1038/s41597-023-02074-6.
10
Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases.生物标志物:用于新冠病毒病及其他疾病诊断、预后评估和治疗的有前景且有价值的工具。
Heliyon. 2023 Feb;9(2):e13323. doi: 10.1016/j.heliyon.2023.e13323. Epub 2023 Jan 30.